Loading…
Alpha Tau Medical Ltd. is projected to rise to $14.75 by 2027, a +25% move from its current price of $11.79. DRTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $11.33 | $11.79 | $12.27 | -0.02% |
| Aug 3 | $11.14 | $11.79 | $12.47 | -0.04% |
| Aug 4 | $11.00 | $11.78 | $12.62 | -0.06% |
| Aug 5 | $10.88 | $11.78 | $12.75 | -0.07% |
| Aug 6 | $10.78 | $11.78 | $12.87 | -0.09% |
| Aug 7 | $10.69 | $11.78 | $12.98 | -0.11% |
| Aug 8 | $10.60 | $11.77 | $13.08 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.60 | $11.77 | $13.08 | -0.13% |
| Week 2 | $10.14 | $11.76 | $13.64 | -0.26% |
| Week 3 | $9.79 | $11.74 | $14.09 | -0.39% |
| Week 4 | $9.51 | $11.73 | $14.47 | -0.52% |
| Week 5 | $9.26 | $11.71 | $14.81 | -0.64% |
| Week 6 | $9.05 | $11.70 | $15.13 | -0.77% |
| Week 7 | $8.85 | $11.68 | $15.43 | -0.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. The Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
The business operates within the Healthcare sector.
Alpha Tau Medical Ltd. trades under the ticker DRTS and sits in the Healthcare sector as a clinical-stage oncology therapeutics company. Its current price is $11.55 and its market capitalization is $1.04B.
The stock is ranked 2414 in the market listings. The overall price outlook shows upside potential over the longer horizon, with the 2026 forecast neutral and subsequent years creating a bullish longer-term trajectory (e.g., rising averages toward 2030 and beyond, including a strong rise by 2040 and 2050).
A major floor 44.4% below — a decisive break under it would weaken the trend.
The nearest floor, 17.0% below — buyers have tended to step in here.
The nearest ceiling, 15.1% above — a clean break opens room to run.
A major ceiling 31.6% above — clearing it would confirm fresh momentum.
Key DRTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.72 | Buy | $11.87 | Sell |
| MA 10 | $12.42 | Sell | $12.12 | Sell |
| MA 20 | $12.57 | Sell | $12.14 | Sell |
| MA 50 | $11.22 | Buy | $11.28 | Buy |
| MA 100 | $9.53 | Buy | $9.96 | Buy |
| MA 200 | $7.52 | Buy | $8.18 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.35 | Neutral |
| Stoch RSI (14) | 24.92 | Neutral |
| CCI (20) | -90.97 | Neutral |
| Williams %R (14) | -74.26 | Info |
| MACD (12,26,9) | -0.26 | Sell |
| ROC (12) | -5.38 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 25.74 | Neutral |
| TRIX (15) | 0.57 | Buy |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 38.85 | Neutral |
| Momentum (10) | -1.76 | Sell |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 11.24 | Buy |
| ADX (14) | 16.51 | Neutral |
| ATR (14) | 0.43 | Info |
The 30-day technical picture is bullish, with RSI(14) at 50. The market displays a short-term uptrend alongside the price action. The 50-day simple moving average stands at $11.07 and the 200-day simple moving average at $7.32, shaping near-term trend lines.
The stock shows support at $9.35 and resistance at $13.57, with a 30-day price range from $8.71 to $15.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.83 | $11.79 | $15.94 | 0% | Neutral | |
| $11.28 | $14.75 | $20.67 | +25% | Bullish | |
| $12.61 | $17.21 | $25.38 | +46% | Bullish | |
| $12.89 | $18.24 | $27.98 | +55% | Bullish | |
| $18.05 | $26.39 | $41.82 | +124% | Bullish | |
| $23.48 | $35.35 | $57.65 | +200% | Bullish | |
| $24.90 | $38.56 | $64.49 | +227% | Bullish | |
| $26.86 | $42.71 | $73.07 | +262% | Bullish | |
| $28.07 | $45.78 | $79.96 | +288% | Bullish | |
| $29.86 | $49.90 | $88.85 | +323% | Bullish | |
| $50.54 | $94.64 | $182.46 | +703% | Bullish | |
| $85.53 | $190.07 | $410.44 | +15.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.83 | $11.79 | $14.25 | +0.00% |
| September 2026 | $9.40 | $11.27 | $14.01 | -4.38% |
| October 2026 | $9.57 | $11.59 | $14.62 | +2.84% |
| November 2026 | $10.05 | $12.28 | $15.67 | +5.90% |
| December 2026 | $10.04 | $12.35 | $15.94 | +0.61% |
Click any year to see its month-by-month DRTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, DRTS could reach as high as $15.94, with a base case around $11.79 and support toward $4.83 — roughly 0% from $11.79. Price action looks broadly range-bound.
Expect DRTS to range from $11.28 to $20.67 through 2027. The $14.75 average target implies a +25% move from current prices. That is up +25% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The DRTS price prediction for 2028 points to an average of $17.21 (low $12.61, high $25.38) — a potential gain of +46% on today's $11.79. Momentum favours further upside here.
In 2029, DRTS is projected to trade between $12.89 and $27.98, averaging $18.24 — a potential gain of +55% from today's $11.79. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Alpha Tau Medical Ltd.'s 2030 outlook centres on $26.39, within a $18.05 to $41.82 range. That is up +45% on the projected 2029 average. That marks a +124% change versus current levels. Momentum favours further upside here.
By 2031, DRTS could reach as high as $57.65, with a base case around $35.35 and support toward $23.48 — roughly +200% from $11.79. Buyers look set to stay in control over this stretch.
Expect DRTS to range from $24.90 to $64.49 through 2032. The $38.56 average target implies a +227% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The DRTS price prediction for 2033 points to an average of $42.71 (low $26.86, high $73.07) — a potential gain of +262% on today's $11.79. Buyers look set to stay in control over this stretch.
In 2034, DRTS is projected to trade between $28.07 and $79.96, averaging $45.78 — a potential gain of +288% from today's $11.79. That is up +7% on the projected 2033 average. Momentum favours further upside here.
Alpha Tau Medical Ltd.'s 2035 outlook centres on $49.90, within a $29.86 to $88.85 range. That is up +9% on the projected 2034 average. That marks a +323% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, DRTS could reach as high as $182.46, with a base case around $94.64 and support toward $50.54 — roughly +703% from $11.79. Momentum favours further upside here.
Expect DRTS to range from $85.53 to $410.44 through 2050. The $190.07 average target implies a +15.1x move from current prices. That is up +101% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DRTS today (≈ 84.817642 DRTS) could be worth
$16,121.59
+$15,121.59 (+1512%) by 2050 · US Dollar
Based on the average projected DRTS price of $190.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRTSwould be worth at today's price.
$1,000 invested in DRTS on Jul 31, 2025 (≈ 325.732906 DRTS) would be worth
$3,840.39
+$2,840.39 (+284.0%) today · 3.84× · US Dollar
Based on a DRTS entry price of $3.07 vs. today's $11.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.5 | $943.2 | -5.7% |
| 1 month ago | $12.64 | $932.75 | -6.7% |
| 3 months ago | $8.54 | $1,380.56 | +38.1% |
| 6 months ago | $6.96 | $1,693.97 | +69.4% |
| 1 year ago | $3.07 | $3,840.39 | +284.0% |
| All time (5.0y) ago | $9.89 | $1,192.11 | +19.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRTS forecast.
Our base-case forecast reaches $24.00 around 2030.
Implied market cap at $24.00: $2.17B
The multi-year forecast shows a clear path of upside after 2026. The 2026 forecast has an average price of $11.55 with a 0% ROI and neutral sentiment. From 2027 onward, the forecast strengthens: 2027 avg $14.37 (ROI 24.4%, bullish), 2028 avg $16.70 (ROI 44.6%, bullish), 2029 avg $17.44 (ROI 51%, bullish).
In 2030 the avg climbs to $26.03 (ROI 125.3%, bullish). The trajectory continues higher in 2031 ($34.96 avg, ROI 202.7%), 2032 ($37.46 avg, ROI 224.3%), 2033 ($41.77 avg, ROI 261.6%), 2034 ($44.49 avg, ROI 285.2%), and 2035 ($47.84 avg, ROI 314.2%), all bullish. The long horizon shows substantial upside in 2040 (avg $91.79, ROI 694.7%, bullish) and 2050 (avg $183.90, ROI 1492.2%, bullish).
These are estimates reflecting bullish momentum in the longer term, but actual results may differ from forecasted values.
Tap a question to reveal the answer.
The 2030 forecast shows min $17.41, avg $26.03, max $42.16; ROI 125.3%; sentiment BULLISH.
Forecasts indicate a bullish trajectory from 2027 onward with notable upside (e.g., 2030 ROI 125.3%; 2050 ROI 1492.2%), but these are estimates and not guarantees.
Yes—the 2031 forecast lists max $58.35 with min $22.63, avg $34.96 and ROI 202.7%, sentiment BULLISH.
The 2040 forecast shows min $46.52, avg $91.79, max $182.68; ROI 694.7%; sentiment BULLISH.
Alpha Tau Medical Ltd. Community Discussion
0Share your Alpha Tau Medical Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.